SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  


    


Butterfield Is First Female President of Society for Immunotherapy of Cancer

Dr. Lisa Butterfield PhD has been elected President of the Society for Immunotherapy of Cancer (SITC), becoming the first woman to hold that position in the society’s 32-year history. She is SITC’s 17th President, and she will serve a two-year term.

Butterfield is a Professor within the Division of Hematology/Oncology, University of Pittsburgh School of Medicine’s Department of Medicine, with secondary appointments in Surgery, Immunology and CTSI. She also directs the UPCI Immunologic Monitoring and Cellular Products Laboratory, which plays a key role in supporting novel investigator-initiated immunotherapy trials at the University of Pittsburgh Cancer Institute. The research in Dr. Butterfield’s lab focuses on the interaction between the immune system and melanoma and hepatocellular cancers.

Dr. Butterfield has previously served as SITC’s Vice President, Secretary/Treasurer, and as a board member of the international organization. SITC has more than 1,700 members, representing 17 medical specialties, who are involved in the research and treatment of cancer. Previous SITC Presidents include founding University of Pittsburgh Cancer Institute Director Ronald B. Herberman MD (1994 – 1996) and UPCI Faculty member Michael T. Lotze MD (1998-2000).